Aprea Therapeutics Inc (APRE)

$3.99

Market is closed - opens 7 PM, 18 Jul 2024

Performance

  • $3.96
    $4.07
    $3.99
    downward going graph

    0.75%

    Downside

    Day's Volatility :2.7%

    Upside

    1.97%

    downward going graph
  • $2.83
    $8.85
    $3.99
    downward going graph

    29.07%

    Downside

    52 Weeks Volatility :68.02%

    Upside

    54.92%

    downward going graph

Returns

PeriodAprea Therapeutics IncIndex (Russel 2000)
3 Months
-28.88%
0.0%
6 Months
-22.83%
0.0%
1 Year
14.0%
0.0%
3 Years
-95.9%
-18.2%

Highlights

Market Capitalization
21.7M
Book Value
$5.33
Earnings Per Share (EPS)
-3.28
Wall Street Target Price
15.67
Profit Margin
0.0%
Operating Margin TTM
-827.62%
Return On Assets TTM
-26.83%
Return On Equity TTM
-43.83%
Revenue TTM
963.8K
Revenue Per Share TTM
0.25
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-14.0M
Diluted Eps TTM
-3.28
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-2.57
EPS Estimate Next Year
-0.78
EPS Estimate Current Quarter
-0.78
EPS Estimate Next Quarter
-0.81

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Aprea Therapeutics Inc(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 292.73%

Current $3.99
Target $15.67

Technicals Summary

Sell

Neutral

Buy

Aprea Therapeutics Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aprea Therapeutics Inc
Aprea Therapeutics Inc
-1.97%
-22.83%
14.0%
-95.9%
-99.03%
Moderna, Inc.
Moderna, Inc.
-6.91%
25.22%
1.18%
-60.44%
769.95%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
4.48%
16.73%
49.42%
85.5%
258.18%
Novo Nordisk A/s
Novo Nordisk A/s
-3.82%
25.91%
69.01%
206.62%
460.98%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.51%
12.79%
36.04%
145.12%
174.23%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aprea Therapeutics Inc
Aprea Therapeutics Inc
0.48
NA
NA
-2.57
-0.44
-0.27
NA
5.33
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
32.36
32.36
1.46
44.28
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
48.58
48.58
2.36
3.45
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.75
31.75
0.53
17.06
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aprea Therapeutics Inc
Aprea Therapeutics Inc
Buy
$21.7M
-99.03%
0.48
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$48.0B
769.95%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$120.7B
258.18%
32.36
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$631.0B
460.98%
48.58
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.2B
174.23%
31.75
39.46%

Insights on Aprea Therapeutics Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 69.0% return, outperforming this stock by 55.0%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 205.5% return, outperforming this stock by 301.5%

Institutional Holdings

  • AIGH Capital Management, LLC

    9.93%
  • Sio Capital Management, LLC

    5.09%
  • Sphera Funds Management Ltd.

    4.97%
  • Nantahala Capital Management, LLC

    3.79%
  • Dafna Capital Management LLC

    2.53%
  • Vanguard Group Inc

    2.14%

Company Information

annan naturvetenskaplig och teknisk forskning och utveckling

Organization
Aprea Therapeutics Inc
Employees
7
CEO
Dr. Oren Gilad Ph.D.
Industry
Commercial Services

FAQs